机构

• 近代物理研究所 [9]
• 国家天文台 [7]
• 过程工程研究所 [6]
• 合肥物质科学研究院 [6]
• 紫金山天文台 [6]
• 大连化学物理研究所 [5]
• 更多

采集方式

• OAI收割 [88]
• iSwitch采集 [3]

内容类型

• 期刊论文 [86]
• 会议论文 [4]
• 学位论文 [1]

发表日期

• 2025 [1]
• 2024 [4]
• 2023 [3]
• 2022 [8]
• 2021 [13]
• 2020 [3]
• 更多

学科主题

• Cell Biolo... [2]
• Endocrinol... [2]
• Physics [2]
• 天文技术与方法 [2]
• Biology [1]
• Chemistry [1]
• 更多

筛选

浏览/检索结果: 共91条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Exploring the impacts of topography on characteristics of urban road network: A global empirical analysis 期刊论文  OAI收割 CITIES, 2025, 卷号: 160, 页码: 105848 作者:  Gu, Xiaoyan;  Wang, Huanjiong;  Lyu, Jinxin;  Zhang, Mengmeng;  Ge, Quansheng   |  收藏  |  浏览/下载：14/0  |  提交时间：2025/04/21 Urban road network  Topography  Fractal dimension  Road circuity  Orientation entropy   Generating Urban Road Networks with Conditional Diffusion Models 期刊论文  OAI收割 ISPRS INTERNATIONAL JOURNAL OF GEO-INFORMATION, 2024, 卷号: 13, 期号: 6, 页码: 203 作者:  Gu, Xiaoyan;  Zhang, Mengmeng;  Lyu, Jinxin;  Ge, Quansheng   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/08/22 road network generation  generative models  diffusion models  geospatial context   Observing heroic behavior and its influencing factors in immersive virtual environments 期刊论文  OAI收割 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 卷号: 121, 期号: 17, 页码: 7 作者:  Jin, Kelou;  Wu, Jie;  Zhang, Ran;  Zhang, Shen;  Wu, Xiaoyan   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/06/14 heroic behavior  virtual reality  perception  empathy  social conformity   Incomplete mixing of isotopically variable melts in the lower oceanic crust and its implications on mantle heterogeneity: Evidence from oceanic cumulates from Mid-Atlantic 期刊论文  OAI收割 CHEMICAL GEOLOGY, 2024, 卷号: 648, 页码: 15 作者:  Wang, Jixin;  Li, Bing;  Zhang, Fangyi;  Liao, Renqiang;  Gu, Xiaoyan   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/06/04 Incomplete melt mixing  Lower crustal gabbros  In -situ plagioclase Sr isotopes  Mid -Atlantic Ridge  Pegmatites   The Born in Guangzhou Cohort Study enables generational genetic discoveries 期刊论文  OAI收割 NATURE, 2024, 卷号: 626, 期号: 7999, 页码: 565-+ 作者:  Huang, Shujia;  Liu, Siyang;  Huang, Mingxi;  He, Jian-Rong;  Wang, Chengrui   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/05/11 Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 2, 页码: 739-753 作者:  Xie, Zhifu;  Zhang, Mei;  Song, Qian;  Cheng, Long;  Zhang, Xinwen   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/03/27 Hypercholesterolemia  Atherosclerosis  Liver  ATP-Citrate lyase (ACLY)  Lipogenesis  Cholesterol efflux  ACLY inhibitor   Genome-wide signatures of the geographic expansion and breeding of soybean 期刊论文  OAI收割 SCIENCE CHINA-LIFE SCIENCES, 2023, 卷号: 66, 期号: 2, 页码: 350-365 作者:  Li, Ying-Hui;  Qin, Chao;  Wang, Li;  Jiao, Chengzhi;  Hong, Huilong   |  收藏  |  浏览/下载：25/0  |  提交时间：2024/03/07 soybean  adaptation  introgression  flowering time  breeding   EVA2.0: Investigating Open-domain Chinese Dialogue Systems with Large-scale Pre-training 期刊论文  OAI收割 Machine Intelligence Research, 2023, 卷号: 20, 期号: 2, 页码: 207-219 作者:  Yuxian Gu;  Jiaxin Wen;  Hao Sun;  Yi Song;  Pei Ke   |  收藏  |  浏览/下载：2/0  |  提交时间：2024/04/23 Natural language processing  deep learning (DL)  large-scale pre-training  dialogue systems  Chinese open-domain conversational model   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：63/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文  OAI收割 GENES CHROMOSOMES & CANCER, 2022 作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping   |  收藏  |  浏览/下载：85/0  |  提交时间：2022/05/16 BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy